These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6157064)

  • 21. Phase I study of spirogermanium given daily.
    Legha SS; Ajani JA; Bodey GP
    J Clin Oncol; 1983 May; 1(5):331-6. PubMed ID: 6668504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
    Hu X; Miller L; Richman S; Hitchman S; Glick G; Liu S; Zhu Y; Crossman M; Nestorov I; Gronke RS; Baker DP; Rogge M; Subramanyam M; Davar G
    J Clin Pharmacol; 2012 Jun; 52(6):798-808. PubMed ID: 21680782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2b.
    Sznol M; Mier JW; Sparano J; Gaynor ER; Weiss GR; Margolin KA; Bar MH; Hawkins MJ; Atkins MB; Dutcher JP
    J Biol Response Mod; 1990 Dec; 9(6):529-37. PubMed ID: 2074439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The present status of clinical studies with interferons in cancer in Britain.
    Priestman TJ
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):119-24. PubMed ID: 6183686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics.
    Grochow LB; Noe DA; Dole GB; Rowinsky EK; Ettinger DS; Graham ML; McGuire WP; Donehower RC
    J Natl Cancer Inst; 1989 Jan; 81(2):124-30. PubMed ID: 2909752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial.
    Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Hayat M; Jasmin C; Schwarzenberg L; Machover D; Ribaud P; De Vassal F; Horoszewicz JS
    Anticancer Res; 1982; 2(1-2):63-6. PubMed ID: 6180675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].
    Halász T; Farkas A; Tolvaj G; Horváth G
    Orv Hetil; 2006 Feb; 147(7):321-4. PubMed ID: 17489160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies.
    Ryan DP; Supko JG; Eder JP; Seiden MV; Demetri G; Lynch TJ; Fischman AJ; Davis J; Jimeno J; Clark JW
    Clin Cancer Res; 2001 Feb; 7(2):231-42. PubMed ID: 11234874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I study of SR-2508 and cyclophosphamide administered by intravenous injection.
    Bailey H; Mulcahy RT; Tutsch KD; Rozental JM; Alberti D; Arzoomanian RZ; Tombes MB; Trump DL; Wilding G
    Cancer Res; 1991 Feb; 51(4):1099-104. PubMed ID: 1825475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis.
    Weimar W; Heijtink RA; ten Kate FJ; Schalm SW; Masurel N; Schellekens H; Cantell K
    Lancet; 1980 Feb; 1(8164):336-8. PubMed ID: 6101791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.
    Gutterman JU; Fine S; Quesada J; Horning SJ; Levine JF; Alexanian R; Bernhardt L; Kramer M; Spiegel H; Colburn W; Trown P; Merigan T; Dziewanowski Z
    Ann Intern Med; 1982 May; 96(5):549-56. PubMed ID: 6176159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I trial of subcutaneously administered recombination tumor necrosis factor to patients with advanced malignancy.
    Zamkoff KW; Newman NB; Rudolph AR; Young J; Poiesz BJ
    J Biol Response Mod; 1989 Oct; 8(5):539-52. PubMed ID: 2795095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I study of human lymphoblastoid interferon in patients with hematological malignancies.
    Rohatiner A; Balkwill F; Malpas JS; Lister TA
    Haematol Blood Transfus; 1981; 26():63-7. PubMed ID: 6172324
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase I evaluation and pharmacokinetic study of pyrazine-2-diazohydroxide administered as a single bolus intravenous injection in patients with advanced solid tumors.
    Supko JG; Balcerzak SP; Kraut EH
    Cancer Res; 1993 Oct; 53(20):4843-9. PubMed ID: 8402671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interferon therapy for malignant brain tumors-present and future (author's transl)].
    Nagai M; Arai T
    No Shinkei Geka; 1982 May; 10(5):463-76. PubMed ID: 6180343
    [No Abstract]   [Full Text] [Related]  

  • 37. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.
    Billiau A; De Somers P; Edy VG; De Clercq E; Heremans H
    Antimicrob Agents Chemother; 1979 Jul; 16(1):56-63. PubMed ID: 475375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
    Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
    Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study.
    Lee KH; Talpaz M; Rothberg JM; Murray JL; Papadopoulos N; Plager C; Benjamin R; Levitt D; Gutterman J
    J Clin Oncol; 1989 Nov; 7(11):1726-32. PubMed ID: 2809685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients.
    Kurzrock R; Rosenblum MG; Quesada JR; Sherwin SA; Itri LM; Gutterman JU
    J Clin Oncol; 1986 Nov; 4(11):1677-83. PubMed ID: 3095504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.